Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LTRN on Nasdaq
Shares outstanding
10,781,082
Price per share
$3.03
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,280,306
Total reported value
$6,910,016
% of total 13F portfolios
0%
Share change
-4,043
Value change
-$64,644
Number of holders
33
Price from insider filings
$3.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bios Equity Partners, LP 10% $4,153,175 1,075,952 CAVU MANAGEMENT, LP 12 Jun 2025

As of 31 Dec 2025, 33 institutional investors reported holding 2,280,306 shares of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN). This represents 21% of the company’s total 10,781,082 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 9.4% 1,009,507 -0.61% 3.7% $3,058,806
VANGUARD GROUP INC 3.6% 384,041 0% 0% $1,163,644
CM Management, LLC 2.1% 225,000 0% 0.57% $681,750
RENAISSANCE TECHNOLOGIES LLC 1% 110,400 +10% 0% $334,512
GEODE CAPITAL MANAGEMENT, LLC 0.9% 96,742 +5.1% 0% $293,191
Voss Capital, LP 0.46% 50,000 0% 0.01% $151,500
BlackRock, Inc. 0.41% 44,253 +2.7% 0% $134,087
DIMENSIONAL FUND ADVISORS LP 0.36% 39,110 -2.6% 0% $118,503
NewEdge Advisors, LLC 0.35% 38,069 -19% 0% $115,354
Westside Investment Management, Inc. 0.33% 35,900 0% 0.02% $108,780
CITADEL ADVISORS LLC 0.31% 32,895 0% $99,672
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.27% 28,820 -26% 0% $87,325
HORIZON KINETICS ASSET MANAGEMENT LLC 0.26% 27,582 -4.2% 0% $83,573
Bank of New York Mellon Corp 0.25% 26,481 0% 0% $80,237
DAVENPORT & Co LLC 0.22% 23,814 -7.7% 0% $72,156
STATE STREET CORP 0.22% 23,652 0% 0% $71,666
Focus Partners Wealth 0.15% 15,982 0% $48,426
NORTHERN TRUST CORP 0.14% 15,589 0% 0% $47,235
CIBC Private Wealth Group LLC 0.14% 15,432 0% $46,759
Cetera Investment Advisers 0.11% 12,228 0% $37,051
UBS Group AG 0.1% 10,627 -68% 0% $32,200
GROUP ONE TRADING LLC 0.04% 4,072 -20% 0% $12,338
SIMPLEX TRADING, LLC 0.02% 2,257 +58% 0% $6,838
SBI Securities Co., Ltd. 0.02% 2,143 0% 0% $6,493
CURIO WEALTH, LLC 0.02% 2,000 0% $6,680

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,280,306 $6,910,016 -$64,644 $3.03 33
2025 Q3 2,284,349 $9,928,721 +$166,361 $4.35 31
2025 Q2 2,241,170 $7,081,768 -$615,229 $3.16 34
2025 Q1 2,423,714 $8,580,099 -$194,908 $3.54 30
2024 Q4 2,499,825 $7,996,845 -$160,960 $3.19 32
2024 Q3 1,335,871 $4,902,351 +$118,888 $3.67 31
2024 Q2 1,286,016 $6,005,302 +$572,129 $4.67 39
2024 Q1 1,108,429 $9,753,422 +$324,907 $8.80 33
2023 Q4 1,155,318 $4,944,504 +$6,767 $4.28 29
2023 Q3 1,153,745 $3,934,035 -$18,036 $3.41 26
2023 Q2 1,152,036 $6,497,253 +$385,814 $5.64 25
2023 Q1 1,083,678 $5,233,851 +$124,192 $4.83 21
2022 Q4 893,594 $5,395,811 -$1,734,422 $6.04 21
2022 Q3 1,436,757 $6,840,000 +$106,232 $4.78 23
2022 Q2 1,417,902 $8,060,000 -$230,429 $5.70 25
2022 Q1 1,452,881 $10,384,000 -$1,687,241 $7.14 25
2021 Q4 1,658,393 $13,121,000 -$563,118 $7.98 31
2021 Q3 1,400,629 $15,656,000 +$604,001 $11.18 24
2021 Q2 1,346,716 $19,660,000 -$1,578,997 $14.60 19
2021 Q1 1,403,470 $25,458,000 +$23,880,194 $18.14 21
2020 Q4 82,988 $1,597,009 -$1,643,167 $19.24 10
2020 Q3 160,127 $3,017,000 +$710,980 $18.84 11
2020 Q2 122,153 $1,551,000 +$1,551,000 $12.39 5